Skip to main content
Clinical Trials/NCT06484049
NCT06484049
Not Yet Recruiting
N/A

Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After Hematopoietic Stem Cell Transplantation

Institute of Hematology & Blood Diseases Hospital, China0 sites20 target enrollmentJuly 30, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hematopoietic Stem Cell Transplantation
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Enrollment
20
Primary Endpoint
To observe changes in cognitive levels in patients aged ≥55 years receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT) before and after allo-HSCT.
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

To investigate the potential improvement in cognitive levels in elderly individuals following hematopoietic stem cell transplantation, which will help better understand the changes in cognitive levels after transplantation in elderly patients, providing crucial reference for future clinical practice and research.

Detailed Description

To investigate the potential improvement in cognitive levels in elderly individuals following hematopoietic stem cell transplantation, which will help better understand the changes in cognitive levels after transplantation in elderly patients, providing crucial reference for future clinical practice and research. To observe changes in cognitive levels in patients aged ≥55 years receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT) before and after allo-HSCT.

Registry
clinicaltrials.gov
Start Date
July 30, 2024
End Date
May 31, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age greater than or equal to 55 years;
  • Patients planning to undergo allogeneic hematopoietic stem cell transplantation.

Exclusion Criteria

  • Patients with active diseases;
  • Presence of central nervous system tumor invasion;
  • Planning to undergo two or more transplantations;
  • Severe cognitive impairments or mental illnesses;
  • Inability to communicate in Mandarin.

Outcomes

Primary Outcomes

To observe changes in cognitive levels in patients aged ≥55 years receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT) before and after allo-HSCT.

Time Frame: 1YEAR

1.Post-transplant Assessment: Cognitive level follow-up assessments at 1 month, 3 months, 6 months, and 1 year post-operation. Evaluation content is consistent with pre-transplant assessments. Cerebrospinal fluid testing is scheduled for 3 months post-transplant.4. Survival and Disease Follow-up: Follow-up for one year after transplantation to observe overall survival rate, disease-free survival rate, etc.

Similar Trials